AnaptysBio Reports $30.3 Million Revenue and $3.9 Million Net Income

AnaptysBio reported $30.3 million in collaboration revenue and $3.9 million in net income for its fiscal first quarter ended September 30, 2026. Diluted earnings per share from continuing operations were $0.11. The company also reported progress on Jemperli and Quimilza and said a judgment in its l…